Initial treatment of idiopathic nephrotic syndrome in children with mycophenolate mofetil vs. prednisone: A prospective, randomized, controlled, multicenter, open, phase III, non-inferiority study (INTENT-Study) - basis for amending the standard?

被引:0
|
作者
Benz, Marcus [1 ]
机构
[1] Univ Hosp Cologne, Children & Adolescents Hosp, Cologne, Germany
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
371
引用
收藏
页码:S166 / S167
页数:2
相关论文
共 21 条
  • [1] Initial Treatment of Idiopathic Nephrotic Syndrome in Children with Mycophenolate Mofetil vs. Prednisone: A Prospective, Randomized, Controlled, Multicenter, Open, Phase 3, Noninferiority Study
    Benz, Marcus R.
    Ehren, Rasmus
    Hoecker, Britta
    Fichtner, Alexander
    Querfeld, Uwe
    Hoyer, Peter F.
    Kemper, Markus J.
    Haffner, Dieter
    Dotsch, Joerg
    Konrad, Martin
    Sander, Anja Christine
    Meis, Jan
    Toenshoff, Burkhard
    Weber, Lutz Thorsten
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [2] Protocol Of An Open, Randomized, Controlled, Multicenter Trial On The Initial Treatment Of Idiopathic Steroid-sensitive Nephrotic Syndrome In Children With Mycophenolate Mofetil Vs. Prednisone: The Intent Study
    Benz, Marcus R.
    Doetsch, Joerg
    Ehren, Rasmus
    Gellermann, Jutta
    Haffner, Dieter
    Hoyer, Peter F.
    Kemper, Markus J.
    Konrad, Martin
    Querfeld, Uwe
    Toenshoff, Burkhard
    Weber, Lutz T.
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1740 - 1740
  • [3] Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study)
    Ehren, Rasmus
    Benz, Marcus R.
    Doetsch, Jorg
    Fichtner, Alexander
    Gellermann, Jutta
    Haffner, Dieter
    Hocker, Britta
    Hoyer, Peter F.
    Kaestner, Baerbel
    Kemper, Markus J.
    Konrad, Martin
    Luntz, Steffen
    Querfeld, Uwe
    Sander, Anja
    Toenshoff, Burkhard
    Weber, Lutz T.
    BMJ OPEN, 2018, 8 (10):
  • [4] Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study
    Sohn, W.
    Lee, O. Y.
    Kwon, J. G.
    Park, K. S.
    Lim, Y. J.
    Kim, T. H.
    Jung, S. W.
    Kim, J. I.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 (09): : 860 - +
  • [5] The HELENA study: Hexvix®-TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy—a prospective randomized controlled open-label multicenter non-inferiority study
    M. Gierth
    J. Breyer
    F. Zeman
    H. M. Fritsche
    J. Cordes
    A. Karl
    D. Zaak
    A. Stenzl
    I. Kausch von Schmeling
    A. Sommerhuber
    T. Zierer
    M. Burger
    R. Mayr
    World Journal of Urology, 2021, 39 : 3799 - 3805
  • [6] Robotic versus Open Pancreatoduodenectomy for Pancreatic and Periampullary Tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial
    Jin, Jiabin
    Shi, Yusheng
    Chen, Mengmin
    Qian, Jianfeng
    Qin, Kai
    Wang, Zhen
    Chen, Wei
    Jin, Weiwei
    Lu, Fengchun
    Li, Zheyong
    Wu, Zehua
    Jian, Li
    Han, Bing
    Liang, Xiao
    Sun, Chuandong
    Wu, Zheng
    Mou, Yiping
    Yin, Xiaoyu
    Huang, Heguang
    Chen, Hao
    Gemenetzis, Georgios
    Deng, Xiaxing
    Peng, Chenghong
    Shen, Baiyong
    TRIALS, 2021, 22 (01)
  • [7] Robotic versus Open Pancreatoduodenectomy for Pancreatic and Periampullary Tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial
    Jiabin Jin
    Yusheng Shi
    Mengmin Chen
    Jianfeng Qian
    Kai Qin
    Zhen Wang
    Wei Chen
    Weiwei Jin
    Fengchun Lu
    Zheyong Li
    Zehua Wu
    Li Jian
    Bing Han
    Xiao Liang
    Chuandong Sun
    Zheng Wu
    Yiping Mou
    Xiaoyu Yin
    Heguang Huang
    Hao Chen
    Georgios Gemenetzis
    Xiaxing Deng
    Chenghong Peng
    Baiyong Shen
    Trials, 22
  • [8] The HELENA study: Hexvix®TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy-a prospective randomized controlled open-label multicenter non-inferiority study
    Gierth, M.
    Breyer, J.
    Zeman, F.
    Fritsche, H. M.
    Cordes, J.
    Karl, A.
    Zaak, D.
    Stenzl, A.
    von Schmeling, I. Kausch
    Sommerhuber, A.
    Zierer, T.
    Burger, M.
    Mayr, R.
    WORLD JOURNAL OF UROLOGY, 2021, 39 (10) : 3799 - 3805
  • [9] Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial
    Chen, Xue
    Han, Xiuping
    Cheng, Bo
    Li, Hui
    Liu, Lingling
    Geng, Songmei
    Li, Linfeng
    Li, Jie
    Guo, Qing
    Zhang, Guoyi
    Fang, Hong
    Zhang, Jianzhong
    CHINESE MEDICAL JOURNAL, 2024, 137 (12) : 1480 - 1482
  • [10] A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study
    Gwenaelle Gravis
    Patricia Marino
    Daniel Olive
    Frederique Penault-LLorca
    Jean-Pierre Delord
    Clotilde Simon
    Assia Lamrani-Ghaouti
    Renaud Sabatier
    Joseph Ciccolini
    Jean-Marie Boher
    BMC Cancer, 23